Development, Acceptability and Preliminary Efficacy of an Internet-Based Self-Help Program

January 3, 2024 updated by: CanSagligi Foundation

Development, Acceptability and Preliminary Efficacy of an Internet-Based Self-Help Program Using Acceptance and Commitment Therapy for Coping With Burnout Among Healthcare Workers: A Randomized Controlled Pilot Study

This study aims to evaluate acceptability and initial effectiveness of an internet-based self-help program utilizing Acceptance and Commitment Therapy specifically for healthcare workers, intending to address burnout.

Study Overview

Detailed Description

This pilot study is a randomized controlled trial of two parallel groups. The study will comprise of an intervention and a wait-list control group. The intention of this study is to evaluate the acceptability and preliminary efficacy of an internet-based self-help program with minimal telephone support utilizing Acceptance and Commitment Therapy for alleviating burnout among healthcare workers.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Uskudar
      • Istanbul, Uskudar, Turkey
        • Recruiting
        • CanSagligi Foundation
        • Contact:
        • Principal Investigator:
          • Ahmet Nalbant, MD
        • Sub-Investigator:
          • Havvanur Uysal Akdemir, MS
        • Sub-Investigator:
          • Edanur Gürbüz, BA
        • Sub-Investigator:
          • Kaasım Fatih Yavuz, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Currently employed in the healthcare field as a doctor, nurse, technician, pharmacist or other healthcare profession for a minimum of six months.
  • Proficiency in using computer and email.
  • Experiencing symptoms of burnout related to the workplace.

Exclusion Criteria:

  • Currently prescribed psychotropic medication.
  • Currently undergoing psychotherapy.
  • Presently experiencing thoughts of suicide or self-mutilation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
The experimental group which will have an immediate access to web-based psychotherapy.
An eight module self help program
No Intervention: Control
A wait-list control group which have one month delayed access to intervention program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Burnout Assessment Tool
Time Frame: At baseline and 4 weeks
Burnout Assessment Tool is a validated measure which evaluates to what extend people experience burnout.
At baseline and 4 weeks
Valued Living Questionnaire (VLQ)
Time Frame: At baseline and 4 weeks
VLQ is a validated measure and its aim is to evaluate valued living.
At baseline and 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptance and Action Questionnaire-2 (AAQ-2)
Time Frame: At baseline and 4 weeks
AAQ-2 is a measure aiming to evaluate experiential avoidance
At baseline and 4 weeks
System Usability Scale (SUS)
Time Frame: 4 weeks
SUS aims to measure evaluations of participants about an internet based program.
4 weeks
Attendance rate
Time Frame: 4 weeks
To evaluate feasibility, participants attendance rate to the program will be recorded.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ahmet Nalbant, MD, CanSagligi Foundation Center for Contextual Behavioral Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2023

Primary Completion (Estimated)

May 1, 2024

Study Completion (Estimated)

December 1, 2024

Study Registration Dates

First Submitted

December 7, 2023

First Submitted That Met QC Criteria

January 3, 2024

First Posted (Actual)

January 5, 2024

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 3, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data would be available upon request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burnout, Professional

3
Subscribe